ZA899113B - Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon - Google Patents

Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon

Info

Publication number
ZA899113B
ZA899113B ZA899113A ZA899113A ZA899113B ZA 899113 B ZA899113 B ZA 899113B ZA 899113 A ZA899113 A ZA 899113A ZA 899113 A ZA899113 A ZA 899113A ZA 899113 B ZA899113 B ZA 899113B
Authority
ZA
South Africa
Prior art keywords
cell carcinoma
squamous cell
recombinant human
intralesionally
treatment
Prior art date
Application number
ZA899113A
Other languages
English (en)
Inventor
Daniel J Tanner
J Tanner Daniel
Edwin A Peets
A Peets Edwin
Kenneth A Smiles
A Smiles Kenneth
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA899113B publication Critical patent/ZA899113B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA899113A 1988-12-01 1989-11-29 Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon ZA899113B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27831588A 1988-12-01 1988-12-01

Publications (1)

Publication Number Publication Date
ZA899113B true ZA899113B (en) 1990-08-29

Family

ID=23064525

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA899113A ZA899113B (en) 1988-12-01 1989-11-29 Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon

Country Status (14)

Country Link
EP (2) EP0446279A1 (ko)
JP (1) JPH0647556B2 (ko)
KR (1) KR950011889B1 (ko)
AT (1) ATE92333T1 (ko)
AU (1) AU634511B2 (ko)
CA (1) CA2004202C (ko)
DE (1) DE68908119T2 (ko)
DK (1) DK103891A (ko)
ES (1) ES2058555T3 (ko)
IE (1) IE63121B1 (ko)
IL (1) IL92495A (ko)
MY (1) MY107071A (ko)
WO (1) WO1990006135A1 (ko)
ZA (1) ZA899113B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06503570A (ja) * 1990-12-14 1994-04-21 シェリング・コーポレーション 肺の悪性腫瘍類を治療するためのアルファーインターフェロンの経口投与
IL100415A0 (en) * 1990-12-21 1992-09-06 Schering Corp Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
EP0859630B1 (en) * 1995-10-04 2002-12-11 Schering Corporation Combination of temozolomide and alpha-ifn for the treatment of advanced cancer
US7294332B2 (en) 1995-10-04 2007-11-13 Schering Corporation Combination therapy (temozolomide and α-IFN) for advanced cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077063B1 (en) * 1981-10-13 1988-03-16 Exovir, Inc. Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
IE62318B1 (en) * 1986-05-27 1995-01-25 Schering Corp Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon

Also Published As

Publication number Publication date
AU634511B2 (en) 1993-02-25
IE63121B1 (en) 1995-03-22
MY107071A (en) 1995-09-30
KR950011889B1 (ko) 1995-10-12
KR900701311A (ko) 1990-12-01
EP0372809A1 (en) 1990-06-13
DE68908119D1 (de) 1993-09-09
AU4802590A (en) 1990-06-26
ES2058555T3 (es) 1994-11-01
EP0446279A1 (en) 1991-09-18
IL92495A0 (en) 1990-08-31
DK103891D0 (da) 1991-05-31
DK103891A (da) 1991-05-31
ATE92333T1 (de) 1993-08-15
CA2004202A1 (en) 1990-06-01
EP0372809B1 (en) 1993-08-04
IL92495A (en) 1995-05-26
DE68908119T2 (de) 1993-11-18
WO1990006135A1 (en) 1990-06-14
JPH04500678A (ja) 1992-02-06
CA2004202C (en) 2001-02-13
JPH0647556B2 (ja) 1994-06-22
IE893828L (en) 1990-06-01

Similar Documents

Publication Publication Date Title
NO176665C (no) Fremgangsmåte for fremstilling av ikke-glykosylert IL-6 og vektor for utskillelse derav
GR851626B (ko)
AU7679787A (en) Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventive or curative treatment of the corresponding tumor
ES8606885A1 (es) Un procedimiento para la produccion de un polipeptido
GB8805792D0 (en) Medicaments
PH23901A (en) Treatment of diabetes using fluoxetine
IL92495A0 (en) Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
DK50987A (da) Polypeptid med plasminogenaktivatorvirkning
EP0248583A3 (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
DK0519902T3 (ko)
EP0180737A3 (en) Use of preparations containing gamma-interferon (ifn-gamma) for treating rheumatic diseases
EP0276120A3 (en) Treatment of certain leukemias with a combination of gamma interferon and alpha interferon
EP0267684A3 (en) Human leukocyte interferon composition and skin treatment
EP0278715A3 (en) Use of human gamma interferon for treatment of basal cell carcinoma
HU900202D0 (en) Process for manufacturing of pharmaceutical compositions comprising gamma-interferon suitable to treatment of ovarion cancer
CS434488A1 (en) Connection of make and break control pulses' source for disconnectable gto thyristors
NO880831D0 (no) Rekombinant human vevsplasminogen-aktivatorblanding.